David First
Officer at SQZ Biotechnologies Co (SQZ)
David First has filed 3 insider reports with the SEC since February 2021, as officer at SQZ Biotechnologies Co (SQZ). The latest filing, on January 26, 2023, reports grant or award at SQZ Biotechnologies Co (SQZ).
- Filings
- 3
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where David First is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Officer | Jan 26, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jan 24, 2023SQZSEC Form 4 filed by First DavidForm 4Grant or award
- Feb 10, 2022SQZSEC Form 4 filed by First DavidForm 4Grant or award
- Feb 23, 2021SQZSEC Form 4 filed by David FirstForm 4Grant or award
Compare David First with
- David First vs Patrick V.j.j. Vink1 shared
- David First vs Sapna Srivastava1 shared
- David First vs Amy W Schulman1 shared
- David First vs Marc Schegerin1 shared
- David First vs Klavs F. Jensen1 shared
- David First vs Pushkal Garg1 shared
Questions about David First
- What is David First's role at SQZ Biotechnologies Co?
- David First reports to the SEC as officer at SQZ Biotechnologies Co (SQZ), according to the latest filing on January 26, 2023.
- Has David First bought or sold stock recently?
- No open-market purchases or sales by David First are on file. The filings report grant or award.
- How do I get alerts when David First files?
- Follow David First on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by David First (SEC CIK 0001767296). Totals count each trade once, skipping amendments whose original is on file, from Feb 25, 2021 on. View on SEC EDGAR · Get this as JSON